The Gut Microbiome and Diet: What to Eat to Build a Healthier Microbiome

The gut-brain axis is a bidirectional communication network involving the vagus nerve, the enteric nervous system (the 'second brain' — a mesh of 500 million neurons lining the GI tract), circulating metabolites, and the immune system. The microbiome influences brain function through at least four overlapping pathways. First, neurotransmitter production: gut bacteria synthesise or modulate the synthesis of serotonin (approximately 90 % of the body's serotonin is produced in the gut), gamma-aminobutyric acid (GABA), dopamine precursors, and short-chain fatty acids that cross the blood-brain barrier. Second, vagal signalling: the vagus nerve carries signals from enteroendocrine cells responding to microbial metabolites directly to the brainstem. Third, immune modulation: the gut houses roughly 70 % of the immune system; microbial metabolites shape inflammatory tone systemically, affecting neuroinflammation. Fourth, tryptophan metabolism: gut bacteria significantly influence whether dietary tryptophan is directed towards serotonin synthesis or towards the kynurenine pathway, which produces compounds implicated in depression and cognitive decline. Multiple observational studies associate low microbiome diversity with higher rates of depression, anxiety, and cognitive impairment. While causality is difficult to establish in humans, mechanistic evidence from germ-free mouse models — in which animals raised without any gut bacteria show dramatic behavioural abnormalities that are reversed by microbiome transplantation — strongly supports a causal relationship between microbiome composition and brain function.

A landmark 2021 study from the Sonnenburg lab at Stanford, published in Cell by Wastyk et al., compared high-fibre and high-fermented-food diets in healthy adults over 17 weeks. The fermented food group — consuming yoghurt, kefir, fermented cottage cheese, kimchi, kombucha and fermented vegetable brine — showed a significant increase in microbiome diversity and a decrease in 19 inflammatory proteins, including interleukin-6 and interleukin-12p70. The high-fibre group did not show increased diversity on average, but participants who started with higher microbiome diversity did show decreased inflammatory markers — suggesting that fibre benefits depend on having the bacteria present to ferment it. Earlier work by David et al. (2014) showed that a plant-based diet dramatically altered microbiome composition within a single day, while an animal-based diet (meat, eggs, cheese) produced significant shifts within 24 hours — primarily increased bile-tolerant organisms and decreased fibre-fermenting species — that partially reversed within days of returning to a mixed diet. The speed of dietary influence is both encouraging (your choices today have effects tomorrow) and sobering (the benefits are not persistent without consistent behaviour).

Akkermansia muciniphila is one of the most intensively researched microbiome species of the past decade. It colonises the mucus layer of the intestine, comprises approximately 3–5 % of the gut microbiome in healthy individuals, and is dramatically reduced in obesity, type 2 diabetes, inflammatory bowel disease and metabolic syndrome. A. muciniphila appears to strengthen the intestinal barrier, reduce endotoxin translocation, and improve insulin sensitivity — findings replicated across multiple mouse and human studies. The foods that most consistently increase A. muciniphila are: polyphenol-rich foods (especially pomegranate, cranberries, concord grapes, and green tea), omega-3 fatty acids, and caloric restriction. Fermented dairy does not directly contain it, but indirectly supports its niche. Bifidobacterium species are among the most studied and robustly beneficial genus in the gut microbiome. They ferment dietary fibre to produce acetate and lactate, lower luminal pH, inhibit pathogens, and support regulatory T-cell development. Foods that most consistently increase Bifidobacterium abundance include: fructooligosaccharides (FOS) from chicory, onions, garlic, leeks and asparagus; galactooligosaccharides (GOS) found in human breast milk and present in small amounts in legumes; inulin (chicory root, Jerusalem artichoke); and fermented dairy products (yoghurt with live cultures, kefir). Lactobacillus species are dominant in fermented foods and the vaginal microbiome. In the gut, they compete with pathogens, produce lactic acid and bacteriocins, and support mucus layer integrity. Fermented foods — particularly yoghurt, kefir, kimchi, sauerkraut and miso — transiently increase luminal Lactobacillus counts, though colonisation is generally temporary without continued dietary input.

These terms are frequently conflated but refer to entirely different interventions. Prebiotics are non-digestible food components — primarily certain dietary fibres and polyphenols — that selectively feed beneficial gut bacteria already resident in the colon. The International Scientific Association for Probiotics and Prebiotics (ISAPP) definition requires that a prebiotic must be selectively utilised by host microorganisms and confer a health benefit. Established prebiotics include inulin, FOS, GOS, pectin, resistant starch (found in cooled cooked potatoes and pasta, green bananas, legumes), and arabinoxylan (from wholegrains). Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Commercially sold probiotics are primarily strains of Lactobacillus and Bifidobacterium. The key distinction is permanence: probiotics generally do not colonise the gut long-term in healthy adults — they pass through, producing transient effects (relevant for traveller's diarrhoea, antibiotic-associated diarrhoea, some IBS symptoms) but rarely altering the established microbiome architecture. Prebiotics, by contrast, can permanently shift the composition of the resident community by selectively enriching beneficial species over time. A synbiotic combines both — for example, a prebiotic-rich diet plus fermented foods — and is currently the most evidence-supported dietary strategy for building a robust, diverse microbiome.

Dysbiosis — an imbalanced gut microbiome characterised by reduced diversity, loss of keystone species, and overgrowth of pathobionts — is associated with a striking range of conditions: type 2 diabetes, obesity, non-alcoholic fatty liver disease, inflammatory bowel disease, colorectal cancer, cardiovascular disease, and neuropsychiatric disorders including depression and Parkinson's disease. Whether dysbiosis causes these conditions or results from them is an active area of research; the evidence suggests both — bidirectional causality with self-reinforcing feedback loops. The mechanism linking gut dysbiosis to systemic metabolic disease most strongly supported by current evidence involves lipopolysaccharide (LPS). LPS is a component of the outer membrane of gram-negative bacteria; when gut permeability increases (as occurs with a low-fibre diet), LPS translocates across the gut epithelium into the bloodstream, activating TLR4 receptors and driving systemic low-grade inflammation — a state termed 'metabolic endotoxaemia' by Patrice Cani's group. This chronic low-grade inflammation impairs insulin signalling, promotes adipose tissue inflammation, and has downstream effects on virtually every organ system. Ultra-processed foods are particularly dysbiotic: emulsifiers such as carboxymethylcellulose and polysorbate 80 have been shown in rodent models to erode the mucus layer and alter microbiome composition in ways that promote metabolic syndrome and colitis, even at dietary concentrations comparable to human consumption.